c-Jun N-terminal kinase-dependent mechanisms in respiratory disease
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Respiratory diseases pose a multifaceted dilemma. Although the symptoms and pathology are obvious and provide multiple opportunities for therapeutic investigation, at the same time, the molecular complexities and prioritisation are overwhelming. Even within a disease such as asthma, the number of inducers, cell types, secondary mediators, chemical changes, immune responses and tissue modifications is remarkable. One means of therapeutically targeting this complexity is to identify individual factors responsible for regulating multiple disease processes. The mitogen-activated protein kinase family integrates multiple diverse stimuli, and, in turn, initiates a cell response by phosphorylating and thereby modulating the activity of many target proteins. The c-Jun N-terminal kinase is a critical regulator of pro-inflammatory genes, tissue remodelling and apoptosis, and, therefore, represents an attractive target for novel therapies. Pre-clinical and clinical investigation into the efficacy of c-Jun N-terminal kinase inhibitors has been ongoing since the late 1990s. Over the course of this work, hypotheses have shifted as to the role of c-Jun N-terminal kinase in the many processes that promote allergic, inflammatory, obstructive and fibrotic diseases of the lung. Inhibition of c-Jun N-terminal kinase may indeed provide a means of suppressing more pathological mechanisms in respiratory disease than first suspected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Belumosudil, or KD025 is a ρ-associated coiled-coil kinase isoform 2 (ROCK2) inhibitor with several pathways of fibrotic modulation: increases pulmonary microvascular endothelial cell necrosis in hypoxia, strengthens the integrity of the pulmonary endothelial barrier, and increases oxidative phosphorylation and inhibits glycolysis in pulmonary microvascular endothelial cells [146–148].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [146]
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · cited 1×
“vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF)) [ 24 ].”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“JNK can phosphorylate other proteins, including, but not limited to, insulin receptor substrate 1 [ 4 ], Src-homology collagen protein (Shc) adaptor proteins [33] and TABLE 1 Observations from mitogen-activated protein (MAP) kinase knockout animals”
BackgroundAP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 2×
“JNKs are intracellular serine-directed protein kinases that phosphorylate, and thereby modulate, the function of target proteins (fig. 2). These target macromolecules include transcription factors, adaptor proteins, cytoskeletal proteins and apoptosis-regulating proteins [ 27 ].”
BackgroundSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 4×
“Perhaps the most well-characterised role of p38 is the regulation of tumour necrosis factor (TNF)-a expression via increased mRNA stability, a mechanism that may also be augmented by JNK [19, 20 ].”
BackgroundResultInfluentialSelf-citationHibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886 · cited 2×
“JNK was first identified as the enzyme responsible for phosphorylating critical serine residues in the N-terminus of c-Jun, a component of the AP-1 transcription factor [ 30 ].”
BackgroundRequirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development
Ip, Y. T., & Davis, R. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80143-9 · Cited by 1,547
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“However, as is not uncommon for ATPcompetitive inhibitors, it is not an entirely selective protein kinase inhibitor [ 44 ].”
BackgroundAbsence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,238
Research works printed but not linked: 6
- 2001, Cancer Res, 61, 3908
- 2000, Am J Physiol, 279, L895
- 2005, Abstr Pap Am Chem Soc, 227, U12
- 2005, J Dermatol Sci, 42, 1
- 2002, Cancer Res, 62, 1343
- 2005, J Am Soc Nephrol, 16, 609A
Cited by
Regulation of the immune response by stress‐activated protein kinases
Rincón, M., & Davis, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00744.x · Cited by 266
Inflammatory Signalings Involved in Airway and Pulmonary Diseases
Lee, I.-T., & Yang, C.-M. (2013) · Mediators of Inflammation · doi:10.1155/2013/791231 · Cited by 243
Leproult, E., Barluenga, S., Moras, D., Wurtz, J.-M., & Winssinger, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101396q · Cited by 193
Models and mechanisms of acute lung injury caused by direct insults
Reiss, L. K., Uhlig, U., & Uhlig, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.11.004 · Cited by 174
Bai, X., Guo, Y.-R., Zhao, Z., Li, X., Dai, D.-Q., Zhang, J., Li, Y.-S., & Zhang, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217772 · Cited by 159
Metadata
- Authors
- Bennett, B. L.
- Affiliations
- Celgene (United States) (US)
- Corresponding author
- Bennett, B. L.
- ORCID
- Bennett, B. L.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2006-08-31
- Volume
- 28
- Issue
- 3
- Pages
- 651-661
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2067954702
- Cited by
- 63
- References
- 99
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 2
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- c-Jun N-terminal kinase, respiratory diseases, asthma, mitogen-activated protein kinase, c-Jun N-terminal kinase inhibitor, tissue remodeling, apoptosis, pulmonary fibrosis, airway inflammation, therapeutic target
- MeSH terms
- Glucocorticoids, Humans, Inflammation, Respiration Disorders, Apoptosis, Inflammation Mediators, Protein Kinase Inhibitors, JNK Mitogen-Activated Protein Kinases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. https://app.cochat.ai/papers/10.1183/09031936.06.00012106
- The paper
- Bennett, B. L. (2006). c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. European Respiratory Journal. https://doi.org/10.1183/09031936.06.00012106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.